Veterinary biotechnology company TheraVet announced on Wednesday the success of its educational webinar dedicated to canine osteosarcoma, organized in collaboration with UK-based Veterinary Instrumentation.

The osteoarticular treatment specialist reports that 520 UK and international veterinarians registered for the event, which took place at the end of 2023, including 38% live participants.

The webinar was designed to present the Walloon company's 'Biocera-Vet' method of treating canine osteosarcoma with cementoplasty.

TheraVe reports that the content of the meeting was well received, with an average score of 8.4 out of 10, and a range of positive feedback from participating professionals.

Copyright (c) 2024 CercleFinance.com. All rights reserved.